Knock Out Opioid Abuse Day: Looking Back and Looking Ahead
YOU MUST SCROLL TO THE BOTTOM OF THIS DOCUMENT TO CONTINUE TO THE VIDEO
Jointly Provided by
& 
Release date: 10/4/24
Expiration date: 12/31/24
Estimated time to complete: 1 hour
Activity Faculty
Christopher M. Jones, Pharm.D., Dr.P.H., M.P.H (CAPT U.S. Public Health Service)
Director of the Center for Substance Abuse Prevention (CSAP)
Substance Abuse and Mental Health Services Administration (SAMHSA)
Faculty Biography
Christopher M. Jones, Pharm.D., Dr.P.H., M.P.H. (CAPT U.S. Public Health Service) currently serves as Director of the Center for Substance Abuse Prevention (CSAP) at the Substance Abuse and Mental Health Services Administration (SAMHSA). CAPT Jones brings a wealth of experience to SAMHSA having led substance use, mental health, and injury and violence prevention policy, program, and research activities for more than a decade. Prior to becoming Director of CSAP, CAPT Jones served as the director of the National Center for Injury Prevention and Control at the Centers for Disease Control and Prevention. During his career, CAPT Jones has served in a variety of leadership roles in the U.S. Department of Health and Human Services (HHS).
Target Audience
This activity has been designed to meet the educational needs of physicians, NPs, PAs, nurses, pharmacists, dentists, and other members of the healthcare team
Learning Objectives
After participating in the activity, learners should be better able to
• Describe the long-term evolution of the U.S. overdose epidemic
• Work with your care team to address the epidemic of opioid addiction and the rising levels of misuse and deaths by recognizing the impact of diversion, harm reduction, and knowing signs and symptoms
• Identify ways to improve your own practices and the practices of your team to prevent prescription drug dependency and addiction among patients.
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and Partnership for a Drug-Free New Jersey. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioners
American Academy of CME, Inc., designates this educational activity for 1.0 ANCC contact hours.
Physician Assistants
American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. Approval is valid until December 31, 2024. PAs should only claim credit commensurate with the extent of their participation.
Pharmacists
This activity provides 1.0 ACPE contact hours (0.1 CEUs) of continuing education credit. Universal Activity Number JA4008191-9999-24-025-H01-P, Knowledge
Dentists
American Academy of CME, Inc. is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at ADA.org/CERP.
American Academy of CME, Inc. designates this activity for 1.0 continuing education credits.
Other HCPs:
Other members of the care team will receive a certificate of participation.
Method of Participation
There are no fees to participate in this activity. Learners must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CE credit for your participation, please complete the post-program evaluation. Your certificate can be printed immediately.
Contact:
For any questions about the web platform or technical issues, please contact: questions@drugfreenj.org.
For any questions about CE credit, please contact: CEServices@academycme.org
Disclosures
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.
Planner Dean Barone, PhD, PA-C, DFAAPA, is on the speakers’ bureaus of Ethicon and Johnson & Johnson. All other planners, faculty, and reviewers have no relevant financial relationships to disclose.
This activity will not review off-label or investigational information.
The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy or Partnership for a Drug-Free New Jersey. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.
Hardware/Software Requirements
LAN/WAN connection
Up-to-date web browser
Privacy
For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm
Copyright
© 2024. Partnership for a Drug-Free New Jersey
